[HTML][HTML] Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: a systematic review and meta-analysis
K Zhou, S Zhao, W Guo, L Ding - Medicine, 2020 - journals.lww.com
Background: Non-small cell lung cancer (NSCLC) has a poor prognosis despite
conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule …
conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule …
Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis.
K Zhou, S Zhao, W Guo, L Ding - Medicine, 2020 - europepmc.org
Background Non-small cell lung cancer (NSCLC) has a poor prognosis despite
conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule …
conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule …
[HTML][HTML] Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis
K Zhou, S Zhao, W Guo, L Ding - Medicine, 2020 - ncbi.nlm.nih.gov
Background: Non-small cell lung cancer (NSCLC) has a poor prognosis despite
conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule …
conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule …
Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis
K Zhou, S Zhao, W Guo, L Ding - Medicine, 2020 - pubmed.ncbi.nlm.nih.gov
Background Non-small cell lung cancer (NSCLC) has a poor prognosis despite
conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule …
conventional treatments of surgery, radiotherapy, and chemotherapy. Small-molecule …